Citation

82 FR 32712

Multiple canonical documents share this first-page citation.

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Monday, July 17, 2017 82 FR 32712
Prospective Grant of Exclusive Patent License: Development, Commercial Application and Use of Fulvestrant in Combination Therapy for the Treatment of Cancers Monday, July 17, 2017 82 FR 32712